HEME-20

Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRD) (HEME-20)

Arms / Cohorts

Experimental:Bone Marrow Minimal Residual Disease Negative

Accepting patients

Experimental:Bone Marrow Minimal Residual Disease Positive

Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.